Roberta Manti

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats.

Manuela Aragno, Silvia Parola, Enrico Brignardello et al. · Diabetes · 2000 · 121 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes

Gabriele Forlani, Carlo Giorda, Roberta Manti et al. · Journal of Diabetes Research · 2016 · 101 citations · Full text

Medicine, Internal Medicine, Clinical Nutrition +15

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11